Is VIBEF or JNJ a better dividend investment in 2026?

VIBEF currently yields 5714.29% with a 5% 5-year dividend growth rate. JNJ yields 2.14% with 5.8% growth. The better choice depends on your goal: VIBEF offers higher current income.

What is the dividend yield difference between VIBEF and JNJ?

VIBEF has a forward dividend yield of 5714.29% ($2.00/share annually). JNJ yields 2.14% ($5.20/share annually). The yield gap is 5712.15 percentage points.

Home › Compare › VIBEF vs JNJ

VIBEF vs JNJ: Dividend Comparison 2026

VIBEF yields 5714.29% · JNJ yields 2.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 VIBEF wins by $228153224412509.56M in total portfolio value

INVESTMENT

TIME HORIZON10 years

VIBEF

● Live price

5714.29%

Share price

$0.04

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$228153224412509.59M

Annual income

$220,560,399,839,122,060,000.00

Full VIBEF calculator →

JNJ

Johnson & Johnson

● Live price

2.14%

Share price

$242.49

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.5K

Annual income

$4,749.88

Full JNJ calculator →

Portfolio growth — VIBEF vs JNJ

📍 VIBEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	VIBEF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, VIBEF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

VIBEF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VIBEF

Annual income on $10K today (after 15% tax)

$485,714.29/yr

After 10yr DRIP, annual income (after tax)

$187,476,339,863,253,750,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$182.28/yr

After 10yr DRIP, annual income (after tax)

$4,037.40/yr

At 15% tax rate, VIBEF beats the other by $187,476,339,863,253,750,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VIBEF + JNJ for your $10,000?

VIBEF: 50%JNJ: 50%

100% JNJ50/50100% VIBEF

Portfolio after 10yr

$114076612206254.81M

Annual income

$110,280,199,919,561,030,000.00/yr

Blended yield

96.67%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VIBEF

No analyst data

Altman Z

-6.1

Piotroski

5/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-5.7% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VIBEF buys

JNJ buys

No recent congressional trades found for VIBEF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricVIBEFJNJ

Forward yield	5714.29% ✓	2.14%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$228153224412509.59M ✓	$30.5K
Annual income after 10y	$220,560,399,839,122,060,000.00 ✓	$4,749.88
Total dividends collected	$227641622319776.13M ✓	$15.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: VIBEF vs JNJ ($10,000, DRIP)

Year	VIBEF Portfolio	VIBEF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$582,129	$571,428.57	$10,594	$274.49	+$571.5K → VIBEF
2	$31,711,186	$31,088,308.22	$11,294	$360.69	+$31.70M → VIBEF
3	$1,616,661,128	$1,582,730,159.44	$12,133	$476.91	+$1616.65M → VIBEF
4	$77,139,944,357	$75,410,116,950.20	$13,156	$635.42	+$77139.93M → VIBEF
5	$3,445,379,409,484	$3,362,839,669,021.90	$14,432	$854.61	+$3445379.40M → VIBEF
6	$144,058,436,084,716	$140,371,880,116,567.28	$16,056	$1,162.76	+$144058436.07M → VIBEF
7	$5,639,412,164,337,400	$5,485,269,637,726,755.00	$18,175	$1,604.53	+$5639412164.32M → VIBEF
8	$206,716,597,857,094,600	$200,682,426,841,253,570.00	$21,009	$2,252.68	+$206716597857.07M → VIBEF
9	$7,096,097,732,137,874,000	$6,874,910,972,430,782,000.00	$24,911	$3,229.73	+$7096097732137.85M → VIBEF
10	$228,153,224,412,509,600,000	$220,560,399,839,122,060,000.00	$30,458	$4,749.88	+$228153224412509.56M → VIBEF

VIBEF vs JNJ: Complete Analysis 2026

VIBEF — Stock

Vibe Growth Corporation engages in the cultivation, production, retail, and distribution of cannabis for recreation and medicinal. The company operates five dispensaries, one distribution, and two cultivation operations, as well as sells its products through its e-commerce platform under the Vibe By California brand. It also involved in the indoor cultivation; commercial distribution and transportation; e-commerce and home delivery; and manufacturing of marijuana products. The company was formerly known as Vibe Bioscience Ltd. and changed its name to Vibe Growth Corporation in October 2020. Vibe Growth Corporation was incorporated in 2020 and is headquartered in Sacramento, California.

Full VIBEF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this VIBEF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VIBEF vs SCHD VIBEF vs JEPI VIBEF vs O VIBEF vs KO VIBEF vs MAIN VIBEF vs ABBV VIBEF vs MRK VIBEF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.